Assessing the Efficacy and Implementation of Nirsevimab for RSV Prevention in Infants: Global Insights and Recommendations for Hong Kong.
| Publicado en: | Pediatric Respirology & Critical Care Medicine Vol. 10; no. 2; pp. 57 - 64 |
|---|---|
| Autor principal: | |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Apr-Jun2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194902937&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194902937 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 25430343 N1XK jtl: Pediatric Respirology & Critical Care Medicine issn: 25430343 maglogo: N pubinfo: dt: Apr-Jun2026 vid: 10 iid: 2 pid: 16919 pub: Wolters Kluwer India Pvt Ltd artinfo: ui: 194902937 194902937 194902937 10.4103/prcm.prcm_19_25 194902937 ppf: 57 ppct: 7 formats: tig: atl: Assessing the Efficacy and Implementation of Nirsevimab for RSV Prevention in Infants: Global Insights and Recommendations for Hong Kong. aug: au: Yip, Ka Wai Ernest affil: School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong sug: subj: Respiratory Syncytial Virus Infections Prevention and Control Antibodies, Monoclonal Therapeutic Use Treatment Outcomes Evaluation Implementation Science Evaluation Immunization Hospitalization Health Policy Program Implementation Public Health Cost Benefit Analysis Health Care Costs Patient Attitudes Maternal Health Services Child Health Services Practice Guidelines Hong Kong Infant Infant: 1-23 months pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|